The Autism Science Foundation is hosting an extraordinary event that will ignite curiosity and spark conversations! 'Day of Learning' is back for its 13th edition, and this time, it's an in-person gathering in the heart of New York City.
On March 26, 2026, mark your calendars and join us at 583 Park Ave for a day filled with groundbreaking insights. Here's a sneak peek at the captivating talks you can expect:
- Josh Gordon, Columbia and NIH: Unraveling the evolving landscape of autism research. But here's where it gets intriguing—how has the field transformed, and what does it mean for future discoveries?
- Helen Tager-Flusberg, Coalition for Autism Scientists, Boston University: A bold discussion on autism scientists speaking out. What are the challenges they face, and how can their voices drive change?
David Mandell, University of Pennsylvania: Exploring the potential of federal ADSI studies. Could these studies hold the key to unlocking new treatments?
John Spiro, Simons Foundation: Uncovering new autism subtypes. And this is the part most researchers are eager to explore—what could this mean for personalized interventions?
Stephan Sanders, Oxford University, and UCSF: Genetic medicines—a promising future? The potential here is immense, but what are the ethical considerations?
Diana Schendel, Drexel University: Delving into the complexities of family recurrence beyond first-degree relatives. How does this impact our understanding of autism's genetic factors?
But wait, there's more! At our previous Day of Learning, we had the honor of hosting renowned experts who shared their groundbreaking work:
- Dr. Allyson Berent: Gene editing and gene therapies for genetically defined autisms—a brave new world of possibilities.
- Dr. Robert Schultz: AI's role in characterizing autism, offering a unique perspective on early diagnosis and intervention.
- Dr. David Amaral: The invaluable contribution of families in autism research, utilizing post-mortem brain tissue to unlock secrets.
- Dr. Rebeca Levy: Personalized treatment for profound autism using organoids and assembloids—a cutting-edge approach.
- Dr. Elena Tenenbaum: AI's potential in understanding early infant development—a window into the earliest signs of autism.
- Dr. Heather Nuske: Wearable devices as a tool to manage severe behaviors in students with profound autism—a practical application of technology.
Don't miss out on being part of this intellectual journey. Join us for a day that promises to inspire, educate, and provoke thought. Will you be there? Share your thoughts on what excites you most about this event and any topics you'd love to see discussed!
